22 March 2006
Lawrence plc
ECO Animal Health - Update on Regulatory Approvals
On 13 February 2006 Lawrence plc announced that the Committee for Veterinary
Medicinal Products (CVMP) of The European Agency for the Evaluation of Medicinal
Products (EMEA) would meet in mid March. At that meeting the CVMP would
consider, amongst others, two Aivlosin applications for the treatment of enteric
(digestive) diseases in pigs submitted by ECO Animal Health, a wholly owned
subsidiary of Lawrence plc.
In line with normal practice, ECO has not been formally advised of the decisions
reached at the CVMP meeting but understands the committee's opinion will be
published after the next EMEA meeting which will be held from 19 to 21 April
2006.
Contacts:
Peter Lawrence
Chairman, Lawrence plc
020 8336 2900
Anthony Spiro
Spiro Financial
020 8949 0428
Philip Davies
Charles Stanley Securities
020 7953 2457
Notes to Editors:
Lawrence plc is a leader in the development, manufacture and distribution of
principally specialist chemical and pharmaceutical products for the animal
health and farming markets worldwide. Our products for these growth markets
incorporate natural ingredients to promote well being and sustainability. We
achieve our financial goals through the careful and responsible application of
science to generate value for our shareholders.